분자영상 및 방사화학

본문글자크기
  • [J Med Chem.] Novel Hypoxia-Inducible Factor 1α (HIF-1α) Inhibitors for Angiogenesis-Related Ocular Diseases: Discovery of a Novel Scaffold via Ring-Truncation Strategy.

    [J Med Chem.] Novel Hypoxia-Inducible Factor 1α (HIF-1α) Inhibitors for Angiogenesis-Related Ocular Diseases: Discovery of a Novel Scaffold via Ring-Truncation Strategy.

    서울의대, 차의대 / 안홍찬, 김정훈*, 서영거*

  • 출처
    J Med Chem.
  • 등재일
    2018 Oct 25
  • 저널이슈번호
    61(20):9266-9286. doi: 10.1021/acs.jmedchem.8b00971. Epub 2018 Oct 9.
  • 내용

    바로가기  >

    Abstract
    Ocular diseases featuring pathologic neovascularization are the leading cause of blindness, and anti-VEGF agents have been conventionally used to treat these diseases. Recently, regulating factors upstream of VEGF, such as HIF-1α, have emerged as a desirable therapeutic approach because the use of anti-VEGF agents is currently being reconsidered due to the VEGF action as a trophic factor. Here, we report a novel scaffold discovered through the complete structure-activity relationship of ring-truncated deguelin analogs in HIF-1α inhibition. Interestingly, analog 6i possessing a 2-fluorobenzene moiety instead of a dimethoxybenzene moiety exhibited excellent HIF-1α inhibitory activity, with an IC50 value of 100 nM. In particular, the further ring-truncated analog 34f, which showed enhanced HIF-1α inhibitory activity compared to analog 2 previously reported by us, inhibited in vitro angiogenesis and effectively suppressed hypoxia-mediated retinal neovascularization. Importantly, the heteroatom-substituted benzene ring as a key structural feature of analog 34f was identified as a novel scaffold for HIF-1α inhibitors that can be used in lieu of a chromene ring.

     


    Author information

    An H1, Lee S1, Lee JM1, Jo DH2, Kim J3, Jeong YS1, Heo MJ1, Cho CS2, Choi H1, Seo JH1, Hwang S1, Lim J1, Kim T1, Jun HO2, Sim J1,4, Lim C1,4, Hur J1, Ahn J1, Kim HS1,4, Seo SY5, Na Y4, Kim SH4, Lee J1, Lee J1, Chung SJ1, Kim YM3, Kim KW1, Kim SG1, Kim JH2,6, Suh YG1,4.
    1
    College of Pharmacy , Seoul National University , Seoul 08826 , Republic of Korea.
    2
    Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute , Seoul National University Hospital , Seoul 03080 , Republic of Korea.
    3
    Department of Molecular and Cellular Biochemistry, School of Medicine , Kangwon National University , Gangwon-do 24341 , Republic of Korea.
    4
    College of Pharmacy , CHA University , Gyeonggi-do 11160 , Republic of Korea.
    5
    College of Pharmacy , Gachon University , Incheon 21936 , Republic of Korea.
    6
    Department of Ophthalmology, College of Medicine , Seoul National University , Seoul 03080 , Republic of Korea.

  • 연구소개
    본 논문은 혈관신생을 조절하는 타겟인 저산소 유도인자 1 (HIF-1)를 저해하는 저분자화합물 개발 의약화학 논문으로, 노인성황반변성, 당뇨병성 망막병증, 미숙아망막병증 등의 혈관신생관련 망막혈관질환 치료 후보물질을 도출하였습니다. 특히, 화합물 개발에 있어 생물학적 활성뿐만 아니라, 유리체강내 주사 또는 점안제 등의 다양한 의약품 전달 경로에 따라 요구되는 의약품의 물리화학적 특성에 대하여 생각해볼 수 있는 좋은 기회가 될 것입니다.
  • 편집위원

    신혈관화를 특징으로 하는 안질환은 실명의 주원인인데, 이는 anti-VEGF 약제로 치료해 왔지만 최근들어 HIF-1a를 이용한 치료법이 대두되고 있다. 이 논문에서는 HIF-1a 억제제로써 새로운 천연물 기반의 ring-truncated deguelin (Deguelin: Mundeulea sericea를 포함하는 식물에서 추출한 rotenoid 화합물) 아날로그들을 개발 후 그 효과를 제시하고 있다.

    2018-11-14 16:53:57

  • 덧글달기
    덧글달기
       IP : 3.19.56.45

    등록